Israel Englander Gossamer Bio, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 5,597,378 shares of GOSS stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,597,378

Previous 6,495,420 13.83%

Holding current value

$4.98 Million

Previous $7.66 Million 34.28%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $458,001 - $1.14 Million	-898,042 Reduced 13.83%	5,597,378 $5.04 Million
Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $1.82 Million - $3.43 Million	2,270,810 Added 53.75%	6,495,420 $7.66 Million
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $8,415 - $18,935	17,533 Added 0.42%	4,224,610 $3.84 Million
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $1.23 Million - $1.92 Million	-1,253,303 Reduced 22.95%	4,207,077 $5.05 Million
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $801,474 - $2.44 Million	834,869 Added 18.05%	5,460,380 $6.88 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $5.74 Million - $42.4 Million	3,296,396 Added 248.01%	4,625,511 $10 Million
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $1.09 Million - $2.26 Million	-151,590 Reduced 10.24%	1,329,115 $15.9 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $7.8 Million - $13 Million	1,307,018 Added 752.51%	1,480,705 $12.4 Million
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $297,130 - $439,710	-35,205 Reduced 16.85%	173,687 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $3.03 Million - $4.22 Million	-299,898 Reduced 58.94%	208,892 $2.36 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $716,488 - $1.31 Million	-98,826 Reduced 16.26%	508,790 $6.4 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $4.53 Million - $5.52 Million	566,354 Added 1372.58%	607,616 $4.93 Million
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $1.35 Million - $1.71 Million	-156,252 Reduced 79.11%	41,262 $382,000
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $1.57 Million - $2.58 Million	-189,670 Reduced 48.99%	197,514 $1.91 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $2.13 Million - $2.78 Million	188,225 Added 94.6%	387,184 $4.81 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $745,644 - $1.25 Million	78,324 Added 64.93%	198,959 $2.59 Million
Q1 2020 May 14, 2020	SELL	$8.0 - $15.48 $704,368 - $1.36 Million	-88,046 Reduced 42.19%	120,635 $1.22 Million
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $3.09 Million - $5.59 Million	208,681 New	208,681 $3.26 Million
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $324,576 - $460,890	-20,135 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $353,973 - $482,635	20,135 New	20,135 $436,000

Others Institutions Holding GOSS

# of Institutions

104

Shares Held

175M

Call Options Held

453K

Put Options Held

543K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $83.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account